SCHEMBL8917002

SCHEMBL8917002

COC(=O)C(C(C)=O)c1ccccc1C(F)(F)F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.44
CNR2 P34972 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
ACP3 P15309 1/20 0.41
HPGD P15428 1/20 0.40
LMNA P02545 2/20 0.39
GAA P10253 1/20 0.39
KMT2A Q03164 2/20 0.39
MAPK1 P28482 2/20 0.38
PPARG P37231 2/20 0.38
POLB P06746 1/20 0.38
KDM4E B2RXH2 1/20 0.37
CACNA1F O60840 1/20 0.37
CACNA1D Q01668 1/20 0.37
CACNA1S Q13698 1/20 0.37
CACNA1C Q13936 1/20 0.37
MAOA P21397 1/20 0.37
MAOB P27338 1/20 0.37
MAPT P10636 1/20 0.36
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7471669 0.82 ACP3 (0.44) ALDH1A1CNR2SMN1; SMN2ACP3LMNA
SCHEMBL7682991 0.82 ACP3 (0.47) ALDH1A1CNR2ACP3HPGDLMNA
SCHEMBL8914226 0.81 CNR2 (0.46) ALDH1A1CNR2SMN1; SMN2ACP3HPGD
SCHEMBL30474559 0.79 CNR2 (0.44) ALDH1A1CNR2SMN1; SMN2ACP3HPGD
SCHEMBL21659215 0.79 CNR2 (0.44) ALDH1A1CNR2SMN1; SMN2ACP3HPGD
SCHEMBL8233462 0.79 CNR2 (0.44) ALDH1A1CNR2SMN1; SMN2ACP3HPGD
SCHEMBL28068541 0.79 CNR2 (0.44) ALDH1A1CNR2SMN1; SMN2ACP3HPGD
SCHEMBL5457910 0.78 IDO1 (0.44) ALDH1A1CNR2SMN1; SMN2HPGDMAPK1
SCHEMBL11176224 0.77 CNR2 (0.36) CNR2SMN1; SMN2ACP3HPGDKMT2A
SCHEMBL16376975 0.77 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2ACP3HPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5670525-A Substituted 4-phenyl-6-amino-nicotinic acid compounds useful in the treatment of CNS disorders BAYER AKTIENGESELLSCHAFT (DE) 1997-09-23 US disclosed